Dr. Anthony K. L. Leung is a Professor of Biochemistry and Molecular Biology at the Johns Hopkins Bloomberg School of Public Health, with joint appointments in the School of Medicine and the Sidney Kimmel Comprehensive Cancer Center. Trained at Oxford, Dundee, and MIT, he leads a lab that pioneers technologies to study PARP biology and ADP-ribosylation across cancer, infection, and neurodegeneration, including the first enzymatic labeling method, ELTA, and the community resource ADPriboDB. He recently launched the school-wide Innovation Translation Council (serving 900+ faculty).

Dr. Leung’s current translational work includes developing first-in-class coronavirus macrodomain inhibitors with support from the Novo Nordisk Foundation. His honors include the Kleberg Foundation Medical Research Award, Johns Hopkins Catalyst and Discovery Awards, the American Cancer Society Research Scholar Award, the American Society for Cell Biology (ASCB)–Gibco Emerging Leader Finalist recognition, and the Shikani/El-Hibri Prize. He has delivered 140+ invited seminars worldwide, including a keynote at the 2025 American Society for Pharmacology and Experimental Therapeutics (ASPET) Annual Meeting.